Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Burn Prevention Practices for Direct Current Cardioversion
jRCT1051210095Active, not recruiting
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of clobetasol in Atrial fibrillation (AFib), atrial flutter (AFL) and atrial tachycardia (AT) (2 arms). Primary endpoint: Incidence of grade I burns on anterior chest at 16 hours. Started Oct 2021; status: active, not recruiting.
02
Drugs
clobetasol
03
Conditions
Atrial fibrillation (AFib)atrial flutter (AFL)atrial tachycardia (AT)
Beyond the preview
Go deeper on jRCT1051210095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051210095.